Records containing: Macular Degeneration
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-07-24Intravitreal Aflibercept in Neovascular Age-related Macular Degeneration (nAMD): an Observational Study Assessing Patient Relevant Outcomes, Real-world Treatment Pattern and Effectiveness
-
CLINICAL_TRIALS study record update · 2023-06-15The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies
-
CLINICAL_TRIALS study record update · 2023-06-07Special Drug Use Investigation of EYLEA for AMD
-
CLINICAL_TRIALS study record update · 2023-05-15Clinical and Genetic Analyzes of Age-related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2023-03-09Pistachios and Neural Macular Pigment; a Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-12-06A Phase III b, Multicenter Study of the Efficacy and Safety of Aflibercept Switch in Patients With Exudative AMD With Detachment of the Retinal Pigment Epithelium and Previously Treated With Ranibizumab Intravitreal Injection. (ARI2)
-
CLINICAL_TRIALS study record update · 2022-11-29Investigation of Retinal Pathology in Eye Diseases Using High Resolution Optical Coherence Tomography (High-Res-OCT)
-
CLINICAL_TRIALS study record update · 2022-11-08Fundus Image-guided Focal Electroretinography, Usability Study
-
CLINICAL_TRIALS study record update · 2022-10-31A Multicenter, Multiple-Dose Study in Neovascular Age-related Macular Degeneration (nAMD) to Evaluate the Safety, Tolerability, Pharmacodynamics, Immunogenicity, and Clinical Effect of Repeat Intravitreal (IVT) Injections of GEM103 as an Adjunct to Standard of Care Aflibercept Therapy
-
CLINICAL_TRIALS study record update · 2022-10-21A Single Centre, Controlled, Investigation to Evaluate the Performance of the Hyperspectral Camera for Retinal Non-invasive Examination Through the Observation of Retinal Oxygenation
-
CLINICAL_TRIALS study record update · 2022-09-23A Multicenter, Open-label, Multiple Dose Study in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration to Evaluate the Safety, Tolerability, Pharmacodynamics, and Immunogenicity of Repeat Intravitreal Injections of GEM103
-
CLINICAL_TRIALS study record update · 2022-08-31Long Term Evaluation of the Safety and Efficacy of Cooling Anesthesia for Local Anesthesia During Intravitreal Injection (COOL-2)
-
CLINICAL_TRIALS study record update · 2022-07-18A Multi-Center, Two-Stage, Open-Label Phase I and Randomized, Active Controlled, Masked Phase II Study to Evaluate the Safety and Efficacy of Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology Compared With Eylea for the Treatment of Recurrent CNV Secondary to AMD
-
CLINICAL_TRIALS study record update · 2022-07-06Safety and Efficacy of Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in the Treatment of Macular Degeneration
-
CLINICAL_TRIALS study record update · 2022-05-17Functional Study of Intronic Variants in Inherited Cone Disorders
-
CLINICAL_TRIALS study record update · 2022-05-12A PHASE 1, DOUBLE-MASKED, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY, TOLERABILITY, IMMUNOGENICITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ESCALATING DOSAGES OF RN6G (PF-04382923) IN SUBJECTS WITH ADVANCED DRY, AGE-RELATED MACULAR DEGENERATION (AMD) INCLUDING GEOGRAPHIC ATROPHY
-
CLINICAL_TRIALS study record update · 2022-04-29Improving Vision in Adults With Macular Degeneration, Study 1: the Effect of Brain Stimulation
-
CLINICAL_TRIALS study record update · 2022-03-21Retrospective Analysis of Naive Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.
-
CLINICAL_TRIALS study record update · 2022-03-11Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
-
CLINICAL_TRIALS study record update · 2021-11-09Adjunctive Photodynamic Therapy for Persistent Disease Activity in Patients With Neovascular Age-Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2021-06-25A Prospective Observational Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America
-
CLINICAL_TRIALS study record update · 2021-05-19Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2021-05-06A Phase II, Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2021-04-08An Open-label, Randomized, Active-controlled, Parallel-group, Phase-3b Study of the Efficacy, Safety, and Tolerability of 2 mg Aflibercept Administered by Intravitreal Injections Using Two Different Treatment Regimens to Subjects With Neovascular Age-related Macular Degeneration (nAMD).
-
CLINICAL_TRIALS study record update · 2021-03-25Clinical and Genetic Assessment of Treatment Response in Patients With Age-related Macular Degeneration Using Intravitreal Aflibercept Injection